Xeomin – A New Face in Neuromodulators

Botox Gets Some Stiff Competiton

Are the lines between your eyes becoming glaringly apparent and making you look old?

If so, you may be considering getting injections.

It used to be that there was only one horse in the neuromodulator stable, but not so anymore. Today we’re going to talk about the newest kid on the block, Xeomin.

What is Xeomin?

Like its competitors Botox and Dysport, Xeomin is a neuromodulator made from botulinum toxin. Neuromodulators block the signals between the nerve and the muscle so that the muscle is actually paralyzed.

Neuromodulators don’t actually fill in your wrinkles like fillers such as Juvaderm do. Instead, when the muscle is paralyzed, it relaxes and lies flat so that the wrinkles smooth out. Thus, they “neuromodulate”, or control the nerves. In comparison, fillers actually do what the name implies – they simply fill the wrinkle in so that it disappears.

How Can Xeomin Be Used?

The FDA approved Xeomin to be used for the cosmetic purpose of treating the glabellar frown lines which are the ones that develop between your eyes, also known as your 11’s. In addition to cosmetic uses, Xeomin, like Botox and Dysport, is also used therapeutically to treat neurological disorders.

There are two main disorders that Xeomin treats effectively. The firs disorder is called cervical dystonia and it affects the nerves in the neck which results in painful spasms and contractions. It can also cause physical deformation. The second disorder that Xeomin is used to treat is blepharospasm. This disorder causes the orbicularis muscle around the eye to involuntarily flicker.

The History and Legal Issues

Xeomin is approved for use in about 20 countries and has been on the market and in use since 2010. More than 80,000 people have been treated with it but Allergan, the maker of Botox, called “shenanigans”. They filed a lawsuit against Merz, the maker of Xeomin, claiming that Merz used confidential marketing and client information gained from former Allergen sales employees to market Xeomin.

In April of 2012, exactly when Merz was planning to launch their large-scale marketing campaign in the US, an American District judge issued an injunction that stopped them in their tracks. Merz can’t market Xeomin in the US for aesthetic uses for 10 months or until the injunction is lifted, whichever comes first. Also during that time, the sale Xeomin for treatment of neurological disorders is limited to certain US territories unless the patient specifically requests Xeomin.

The US isn’t the only country to side with Allergan either; courts in Spain and Germany issued injunctions about how Merz may compare dosages of Xeomin to Botox.

There are doctors who are conducting studies that evaluate the effectiveness of Xeomin that most likely won’t be affected by the ruling. However, if you really want to use Zeomin, you’re going to have to wait it out for a few more months.

How Does it Work in Comparison to Other Neuromodulators?

Excellent question, and one that deserves its own page. Let’s move on and discuss in detail how Xeomin stacks up to its biggest competitor in our next article, Xeomin Vs Botox.

Be the first! Share your experience!


Tell Us What You Think!

Spam protection (register to skip this)

Time limit is exhausted. Please reload the CAPTCHA.